Synbiotic approaches to human health and well‐being. Issue 5 (3rd August 2017)

• Record Type: Journal Article
• Authors: Gurry, Thomas
• Other Names: Morgenroth Eberhard guestEditor.; Flemming Hans‐Curt guestEditor.; Azeredo Joana guestEditor.; Melo Luis F. guestEditor.; Espinosa Manuel guestEditor.; Whiteley Marvin guestEditor.; Briandet Romain guestEditor.
• Is Part Of: Microbial biotechnology. Volume 10:Issue 5(2017:Sep.)
• Page Start: 1070
• Page End: 1073
• Publication Date: 2017-08-03
• Subjects: Microbial biotechnology -- Periodicals; Biotechnology; Microbiology; 660.62
• DOI: 10.1111/1751-7915.12789
• Languages: English
• ISSNs: 1751-7915

Abstract

Summary: Synbiotics refer to combinations of probiotics and prebiotics that act synergistically to confer health benefits to the host. As a therapeutic strategy, they provide a gentle yet powerful method for modulating the composition and metabolic output of the human gut microbiota. In the context of achieving the UN Sustainable Development Goals, synbiotics have the potential to act as cost‐effective prophylactic measures against a variety of human ailments, ranging from infant diarrhoea to metabolic and inflammatory diseases in adults, by maintaining commensal microbial communities and metabolic networks that are conducive to human health. Abstract : Synbiotics refer to combinations of probiotics and associated prebiotics that act synergistically to confer health benefits to the host. As a therapeutic tool for rational engineering of the composition and metabolic output of a subject's gut microbiota, they have the potential to strengthen existing prophylactic measures aiming to prevent a number of conditions, including infant diarrhoea, inflammatory bowel diseases and metabolic diseases, with important ramifications for sustainable development.